Warfarin During Pregnancy: Why It's Usually Avoided

What does the evidence say about warfarin during pregnancy?

1. The current warfarin label says warfarin is contraindicated in pregnancy except for selected patients with mechanical heart valves at high clot risk, because exposure can cause fetal bleeding, pregnancy loss, fetal death, and a characteristic embryopathy. It directs patients who may be pregnant to contact their physician immediately. 1
2. An NCBI clinical reference says low-molecular-weight heparin and unfractionated heparin do not cross the placenta and identifies low-molecular-weight heparin as the preferred agent for pregnancy venous thromboembolism. Mechanical valves remain a specialized exception requiring individualized anticoagulation. 2
3. The Society for Maternal-Fetal Medicine states that mechanical heart valves carry high maternal morbidity and mortality risk in pregnancy and recommends individualized regimen changes based on valve type, trimester, tolerance, and delivery planning rather than a single universal switch schedule. 3
4. A meta-analysis of 51 observational studies covering 2,113 mechanical-valve pregnancies found fewer maternal major clot events with a low-dose vitamin K antagonist regimen than with first-trimester heparin followed by a vitamin K antagonist. A separate comparison favored all-pregnancy low-molecular-weight heparin for fetal loss. Nonrandomized, varied regimens limit conclusions for any individual. 4
5. LactMed reports very low warfarin levels in human milk, no adverse infant effects in published reports, and professional consensus that maternal warfarin poses little breastfeeding risk. The evidence includes small, older milk and infant-plasma series rather than large outcome trials. 5

Is warfarin safe in each trimester?

• First trimester. First-trimester warfarin exposure is associated with embryopathy and pregnancy-loss concerns. Contact the anticoagulation prescriber and obstetric team urgently after a positive pregnancy test, but do not skip a dose or self-switch because clot risk can be serious.
• Second trimester. For a mechanical heart valve, second-trimester anticoagulation can involve competing maternal thrombosis and fetal risks. Published strategies vary by valve, warfarin requirement, and monitored heparin response, so specialist monitoring is essential.
• Third trimester. Late-pregnancy warfarin planning must account for fetal and maternal bleeding, labor onset, cesarean possibility, and neuraxial anesthesia. The transition timing is individualized and must be written by the anticoagulation and delivery teams.